A Study of LY3451838 in Participants With Migraine

NCT04498910 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: LY3451838
DRUG: Placebo

Sponsor

Eli Lilly and Company